A recent clinical study by Jan-Ake Gustafsson showed that ADT, such as finasteride (5α-reductase inhibitor), enzalutamide (AR blocker), and abiraterone (androgen synthesis inhibitor), promoted EGFR nuclear translocation and increased PCa proliferation on the treatment of PCa. Here, EGFR is linked to posterior cortical atrophy.